Abeona Therapeutics
ABEO
ABEO
48 hedge funds and large institutions have $70.9M invested in Abeona Therapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 40 → 48 (+8)
6.76% more ownership
Funds ownership: 50.39% → 57.15% (+6.8%)
Holders
48
Holding in Top 10
1
Calls
$3.22M
Puts
$303K
Top Buyers
1 | +$3.01M | |
2 | +$2.93M | |
3 | +$2.13M | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.74M |
5 |
Walleye Capital
New York
|
+$942K |
Top Sellers
1 | -$2.11M | |
2 | -$1.74M | |
3 | -$1.01M | |
4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$648K |
5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$425K |